Dr. Savitha Balaraman, MD
Claim this profileMichigan Center of Medical Research
Studies Lung Cancer
Studies Breast Cancer
7 reported clinical trials
11 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
EGFR negative
2Breast Cancer
metastatic
ER
HER2
Affiliated Hospitals
Clinical Trials Savitha Balaraman, MD is currently running
Targeted Alpha-Particle Therapy
for Neuroendocrine Tumors
This study is Phase I/IIa First-in-Human Study of \[212Pb\]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
Recruiting1 award Phase 1 & 213 criteria
TTFields + Pembrolizumab
for Lung Cancer
This is a multicenter, randomized, open-label study of Tumor Treating Fields (TTFields) at 150 kHz to the thorax using the NovoTTF-200T System with IV pembrolizumab in subjects previously untreated for advanced or metastatic, PD-L1 positive non-small cell lung cancer (NSCLC). The primary objective is to evaluate the progression-free survival (PFS) by RECIST 1.1 in subjects with TPS ≥1 percent, 1L metastatic/current advanced NSCLC treated with TTFields concomitant with pembrolizumab compared to those treated with pembrolizumab alone. The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields (termed TTFields) to the region of the malignant tumor, by means of surface, insulated electrode arrays.
Recruiting1 award Phase 28 criteria
More about Savitha Balaraman, MD
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Savitha Balaraman, MD has experience with
- Enobosarm
- Exemestane
- XB2001
- Cemiplimab
- ISA101b
- Placebo
Breakdown of trials Savitha Balaraman, MD has run
Lung Cancer
Breast Cancer
Pancreatic Cancer
Squamous Cell Carcinoma
Human Papillomavirus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Savitha Balaraman, MD specialize in?
Savitha Balaraman, MD focuses on Lung Cancer and Breast Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Savitha Balaraman, MD currently recruiting for clinical trials?
Yes, Savitha Balaraman, MD is currently recruiting for 2 clinical trials in Farmington Hills Michigan. If you're interested in participating, you should apply.
Are there any treatments that Savitha Balaraman, MD has studied deeply?
Yes, Savitha Balaraman, MD has studied treatments such as Enobosarm, Exemestane, XB2001.
What is the best way to schedule an appointment with Savitha Balaraman, MD?
Apply for one of the trials that Savitha Balaraman, MD is conducting.
What is the office address of Savitha Balaraman, MD?
The office of Savitha Balaraman, MD is located at: Michigan Center of Medical Research, Farmington Hills, Michigan 48334 United States. This is the address for their practice at the Michigan Center of Medical Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.